Garcia Hamilton & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,070
Closed -$323K 8
2017
Q3
$323K Sell
5,070
-6,261
-55% -$366K 0.84% 32
2017
Q2
$631K Sell
11,331
-7,284
-39% -$396K 0.87% 39
2017
Q1
$1.04M Sell
18,615
-16,216
-47% -$889K 0.92% 40
2016
Q4
$2.04M Sell
34,831
-2,048
-6% -$112K 1.18% 34
2016
Q3
$1.99M Buy
36,879
+201
+0.5% +$12.9K 1.17% 33
2016
Q2
$2.7M Sell
36,678
-1,401
-4% -$99K 1.63% 21
2016
Q1
$2.43M Buy
38,079
+8,584
+29% +$541K 1.41% 27
2015
Q4
$2.03M Buy
29,495
+358
+1% +$23.7K 1.19% 36
2015
Q3
$1.73M Buy
29,137
+778
+3% +$49.4K 1.06% 41
2015
Q2
$1.89M Buy
28,359
+5,480
+24% +$361K 1.05% 44
2015
Q1
$1.48M Sell
22,879
-6,353
-22% -$398K 0.72% 53
2014
Q4
$1.73M Sell
29,232
-12,717
-30% -$717K 0.67% 54
2014
Q3
$2.15M Buy
+41,949
New +$2.1M 0.62% 57

Other funds holding BMY

Garcia Hamilton & Associates's BMY Position: Q4 2017 in Review

Garcia Hamilton & Associates sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 5,070 shares — an estimated $323K sold.

Garcia Hamilton & Associates first reported a position in BMY in Q3 2014 and held it in 13 quarters. The position peaked at $2.7M in Q2 2016. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • Garcia Hamilton & Associates reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
  • Garcia Hamilton & Associates sold 5,070 Bristol-Myers Squibb shares in Q4 2017, an estimated $323K.
  • Garcia Hamilton & Associates first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 13 quarters.
  • Garcia Hamilton & Associates's Bristol-Myers Squibb position peaked at $2.7M in Q2 2016.
  • 1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Garcia Hamilton & Associates's 13F filing for Q4 2017, filed 19 Jan 2018.